Suntrust Banks’s PDL BioPharma, Inc. PDLI Stock Holding History

Suntrust Banks’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-27,992	Closed	-$59K	–	1630
2016 Q4	$59K	Hold	27,992	–	–	﹤0.01%	1551
2016 Q3	$93K	Buy	27,992 +1,657	+6%	+$5.26K	﹤0.01%	1514
2016 Q2	$82K	Buy	26,335 +1,464	+6%	+$4.88K	﹤0.01%	1474
2016 Q1	$82K	Sell	24,871 -2,651	-10%	-$8.26K	﹤0.01%	1432
2015 Q4	$97K	Buy	+27,522	New	+$115K	﹤0.01%	1409
2014 Q2	–	Sell	-12,002	Closed	-$99K	–	1929
2014 Q1	$99K	Hold	12,002	–	–	﹤0.01%	1849
2013 Q4	$101K	Sell	12,002 -30,000	-71%	-$253K	﹤0.01%	1780
2013 Q3	$334K	Sell	42,002 -130	-0.3%	-$1.04K	﹤0.01%	1434
2013 Q2	$324K	Buy	+42,132	New	+$329K	﹤0.01%	1374

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Suntrust Banks's PDLI Position: Q1 2017 in Review

Suntrust Banks sold out of PDL BioPharma, Inc. (PDLI) in Q1 2017, closing a stake of 27,992 shares — an estimated $59K sold.

Suntrust Banks first reported a position in PDLI in Q2 2013 and held it in 9 quarters. The position peaked at $334K in Q3 2013. 174 funds tracked by Wall St. Rank hold PDLI as of Q1 2017.

Suntrust Banks reported no remaining PDL BioPharma, Inc. position as of Q1 2017 after selling out during the quarter.
Suntrust Banks sold 27,992 PDL BioPharma, Inc. shares in Q1 2017, an estimated $59K.
Suntrust Banks first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 9 quarters.
Suntrust Banks's PDL BioPharma, Inc. position peaked at $334K in Q3 2013.
174 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2017.

Based on Suntrust Banks's 13F filing for Q1 2017, filed 3 May 2017.